Nantahala Capital Management
Latest statistics and disclosures from Nantahala Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IWM, IWM, PTON, PTON, HGV, and represent 26.03% of Nantahala Capital Management's stock portfolio.
- Added to shares of these 10 stocks: QTUM (+$37M), NBIX (+$34M), PRAX (+$34M), KRYS (+$32M), SNAP (+$22M), ADMA (+$20M), XBI (+$16M), VOR (+$16M), PLNT (+$15M), AMAN (+$12M).
- Started 26 new stock positions in INSP, AZTR, ADMA, QTUM, SNTI, CATX, IACQU, EDIT, TRAX, ARTV.
- Reduced shares in these 10 stocks: Soleno Therapeutics (-$84M), QURE (-$65M), PTON (-$50M), Teva Pharmaceutical Industries (-$45M), ESTA (-$43M), HGV (-$25M), TNGX (-$23M), AVR (-$21M), ALGN (-$17M), IWM (-$15M).
- Sold out of its positions in GRCE, ACHV, ALGN, Assertio Holdings, CZR, Centessa Pharmaceuticals, CGON, COGT, DNTH, IRON. Immunic, KOS, NNBR, PEPG, RVMD, Senti Biosciences, Soleno Therapeutics, SLDB, Teva Pharmaceutical Industries, UPB, XNCR, PERFF.
- Nantahala Capital Management was a net seller of stock by $-187M.
- Nantahala Capital Management has $6.0B in assets under management (AUM), dropping by 121.58%.
- Central Index Key (CIK): 0001472322
Tip: Access up to 7 years of quarterly data
Positions held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nantahala Capital Management
Nantahala Capital Management holds 279 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 10.0 | $601M | -2% | 2.0M | 300.45 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 10.0 | $601M | -2% | 2.0M | 300.45 |
|
| Peloton Interactive Cl A Com (PTON) | 2.1 | $127M | -28% | 22M | 5.91 |
|
| Peloton Interactive Cl A Com (PTON) | 2.1 | $127M | -28% | 22M | 5.91 |
|
| Hilton Grand Vacations (HGV) | 1.8 | $110M | -18% | 2.1M | 52.37 |
|
| Hilton Grand Vacations (HGV) | 1.8 | $110M | -18% | 2.1M | 52.37 |
|
| Herbalife Com Shs (HLF) | 1.7 | $101M | +10% | 7.7M | 13.15 |
|
| Herbalife Com Shs (HLF) | 1.7 | $101M | +10% | 7.7M | 13.15 |
|
| Ban (TBBK) | 1.4 | $86M | -9% | 1.4M | 62.64 |
|
| Ban (TBBK) | 1.4 | $86M | -9% | 1.4M | 62.64 |
|
| Viatris Call Option (VTRS) | 1.3 | $79M | 5.0M | 15.88 |
|
|
| Viatris Call Option (VTRS) | 1.3 | $79M | 5.0M | 15.88 |
|
|
| Edwards Lifesciences Put Option (EW) | 1.2 | $72M | 800k | 90.46 |
|
|
| Edwards Lifesciences Put Option (EW) | 1.2 | $72M | 800k | 90.46 |
|
|
| Uniqure Nv SHS (QURE) | 1.1 | $65M | -50% | 1.4M | 46.06 |
|
| Uniqure Nv SHS (QURE) | 1.1 | $65M | -50% | 1.4M | 46.06 |
|
| Spdr Series Trust St Str Sp Biot Put Option (XBI) | 1.1 | $63M | +33% | 400k | 158.25 |
|
| Spdr Series Trust St Str Sp Biot Put Option (XBI) | 1.1 | $63M | +33% | 400k | 158.25 |
|
| Bioventus Com Cl A (BVS) | 0.9 | $57M | 6.0M | 9.44 |
|
|
| Bioventus Com Cl A (BVS) | 0.9 | $57M | 6.0M | 9.44 |
|
|
| Savara (SVRA) | 0.7 | $43M | -5% | 7.0M | 6.16 |
|
| Savara (SVRA) | 0.7 | $43M | -5% | 7.0M | 6.16 |
|
| Eton Pharmaceuticals (ETON) | 0.7 | $43M | 1.2M | 36.20 |
|
|
| Eton Pharmaceuticals (ETON) | 0.7 | $43M | 1.2M | 36.20 |
|
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.7 | $39M | -20% | 2.3M | 17.31 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.7 | $39M | -20% | 2.3M | 17.31 |
|
| Evolus (EOLS) | 0.6 | $39M | -12% | 5.6M | 6.94 |
|
| Evolus (EOLS) | 0.6 | $39M | -12% | 5.6M | 6.94 |
|
| Abeona Therapeutics Com New (ABEO) | 0.6 | $38M | +2% | 6.2M | 6.18 |
|
| Abeona Therapeutics Com New (ABEO) | 0.6 | $38M | +2% | 6.2M | 6.18 |
|
| Etf Ser Solutions Defia Quant Etf Put Option (QTUM) | 0.6 | $37M | NEW | 223k | 165.38 |
|
| Etf Ser Solutions Defia Quant Etf Put Option (QTUM) | 0.6 | $37M | NEW | 223k | 165.38 |
|
| Fox Factory Hldg (FOXF) | 0.6 | $36M | -7% | 2.1M | 16.95 |
|
| Fox Factory Hldg (FOXF) | 0.6 | $36M | -7% | 2.1M | 16.95 |
|
| Camping World Hldgs Cl A (CWH) | 0.6 | $35M | -13% | 4.6M | 7.63 |
|
| Camping World Hldgs Cl A (CWH) | 0.6 | $35M | -13% | 4.6M | 7.63 |
|
| Avalo Therapeutics Com New (AVTX) | 0.6 | $34M | +50% | 1.9M | 18.48 |
|
| Avalo Therapeutics Com New (AVTX) | 0.6 | $34M | +50% | 1.9M | 18.48 |
|
| Lb Pharmaceuticals Com Shs (LBRX) | 0.6 | $34M | 1.1M | 32.45 |
|
|
| Lb Pharmaceuticals Com Shs (LBRX) | 0.6 | $34M | 1.1M | 32.45 |
|
|
| Neurocrine Biosciences Call Option (NBIX) | 0.6 | $34M | NEW | 200k | 168.53 |
|
| Neurocrine Biosciences Call Option (NBIX) | 0.6 | $34M | NEW | 200k | 168.53 |
|
| Praxis Precision Medicines I Com New Put Option (PRAX) | 0.6 | $34M | NEW | 100k | 334.79 |
|
| Praxis Precision Medicines I Com New Put Option (PRAX) | 0.6 | $34M | NEW | 100k | 334.79 |
|
| Anteris Technologies Global (AVR) | 0.6 | $33M | -38% | 3.4M | 9.85 |
|
| Anteris Technologies Global (AVR) | 0.6 | $33M | -38% | 3.4M | 9.85 |
|
| Ridenow Group Com Cl B (RDNW) | 0.6 | $33M | 5.0M | 6.66 |
|
|
| Ridenow Group Com Cl B (RDNW) | 0.6 | $33M | 5.0M | 6.66 |
|
|
| Krystal Biotech Put Option (KRYS) | 0.5 | $32M | NEW | 85k | 371.67 |
|
| Krystal Biotech Put Option (KRYS) | 0.5 | $32M | NEW | 85k | 371.67 |
|
| Establishment Labs Holdings Ord (ESTA) | 0.5 | $29M | -59% | 336k | 85.81 |
|
| Establishment Labs Holdings Ord (ESTA) | 0.5 | $29M | -59% | 336k | 85.81 |
|
| Xtant Med Hldgs Com New (XTNT) | 0.5 | $29M | 68M | 0.42 |
|
|
| Xtant Med Hldgs Com New (XTNT) | 0.5 | $29M | 68M | 0.42 |
|
|
| Jack in the Box (JACK) | 0.5 | $27M | +12% | 1.7M | 15.81 |
|
| Jack in the Box (JACK) | 0.5 | $27M | +12% | 1.7M | 15.81 |
|
| Gogo (GOGO) | 0.4 | $27M | -2% | 8.7M | 3.10 |
|
| Gogo (GOGO) | 0.4 | $27M | -2% | 8.7M | 3.10 |
|
| Imax Corp Cad (IMAX) | 0.4 | $26M | +27% | 658k | 39.86 |
|
| Imax Corp Cad (IMAX) | 0.4 | $26M | +27% | 658k | 39.86 |
|
| Zevra Therapeutics Com New (ZVRA) | 0.4 | $26M | -28% | 1.8M | 14.34 |
|
| Zevra Therapeutics Com New (ZVRA) | 0.4 | $26M | -28% | 1.8M | 14.34 |
|
| Regeneron Pharmaceuticals Call Option (REGN) | 0.4 | $25M | 40k | 623.54 |
|
|
| Regeneron Pharmaceuticals Call Option (REGN) | 0.4 | $25M | 40k | 623.54 |
|
|
| Titan Machinery (TITN) | 0.4 | $24M | -9% | 1.1M | 21.12 |
|
| Titan Machinery (TITN) | 0.4 | $24M | -9% | 1.1M | 21.12 |
|
| Rmr Group Cl A (RMR) | 0.4 | $24M | 1.1M | 20.53 |
|
|
| Rmr Group Cl A (RMR) | 0.4 | $24M | 1.1M | 20.53 |
|
|
| Fossil (FOSL) | 0.4 | $23M | 5.5M | 4.14 |
|
|
| Fossil (FOSL) | 0.4 | $23M | 5.5M | 4.14 |
|
|
| Snap Cl A (SNAP) | 0.4 | $22M | NEW | 5.0M | 4.44 |
|
| Snap Cl A (SNAP) | 0.4 | $22M | NEW | 5.0M | 4.44 |
|
| Mineralys Therapeutics (MLYS) | 0.4 | $22M | -8% | 821k | 26.98 |
|
| Mineralys Therapeutics (MLYS) | 0.4 | $22M | -8% | 821k | 26.98 |
|
| Aura Biosciences (AURA) | 0.3 | $21M | +39% | 3.0M | 7.10 |
|
| Aura Biosciences (AURA) | 0.3 | $21M | +39% | 3.0M | 7.10 |
|
| Agomab Therapeutics Nv Sponsored Ads (AGMB) | 0.3 | $20M | +30% | 1.6M | 12.98 |
|
| Agomab Therapeutics Nv Sponsored Ads (AGMB) | 0.3 | $20M | +30% | 1.6M | 12.98 |
|
| Fulcrum Therapeutics (FULC) | 0.3 | $20M | +79% | 5.5M | 3.66 |
|
| Fulcrum Therapeutics (FULC) | 0.3 | $20M | +79% | 5.5M | 3.66 |
|
| Benitec Biopharma Com New (BNTC) | 0.3 | $20M | +3% | 1.5M | 13.38 |
|
| Benitec Biopharma Com New (BNTC) | 0.3 | $20M | +3% | 1.5M | 13.38 |
|
| Adma Biologics (ADMA) | 0.3 | $20M | NEW | 2.4M | 8.37 |
|
| Adma Biologics (ADMA) | 0.3 | $20M | NEW | 2.4M | 8.37 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $19M | -4% | 1.9M | 10.00 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $19M | -4% | 1.9M | 10.00 |
|
| MiMedx (MDXG) | 0.3 | $18M | +40% | 4.8M | 3.85 |
|
| MiMedx (MDXG) | 0.3 | $18M | +40% | 4.8M | 3.85 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.3 | $18M | -2% | 134k | 133.26 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.3 | $18M | -2% | 134k | 133.26 |
|
| USANA Health Sciences (USNA) | 0.3 | $17M | 810k | 21.35 |
|
|
| USANA Health Sciences (USNA) | 0.3 | $17M | 810k | 21.35 |
|
|
| Chime Finl Com Shs Cl A (CHYM) | 0.3 | $16M | -3% | 772k | 20.48 |
|
| Chime Finl Com Shs Cl A (CHYM) | 0.3 | $16M | -3% | 772k | 20.48 |
|
| Monte Rosa Therapeutics (GLUE) | 0.3 | $16M | 652k | 24.20 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.3 | $16M | 652k | 24.20 |
|
|
| Tango Therapeutics (TNGX) | 0.3 | $16M | -59% | 501k | 31.26 |
|
| Tango Therapeutics (TNGX) | 0.3 | $16M | -59% | 501k | 31.26 |
|
| Geron Corporation (GERN) | 0.3 | $16M | +8% | 12M | 1.28 |
|
| Geron Corporation (GERN) | 0.3 | $16M | +8% | 12M | 1.28 |
|
| Vor Biopharma Com New (VOR) | 0.3 | $16M | NEW | 845k | 18.41 |
|
| Vor Biopharma Com New (VOR) | 0.3 | $16M | NEW | 845k | 18.41 |
|
| Keros Therapeutics (KROS) | 0.3 | $15M | +3% | 1.4M | 10.70 |
|
| Keros Therapeutics (KROS) | 0.3 | $15M | +3% | 1.4M | 10.70 |
|
| Vaxcyte (PCVX) | 0.2 | $15M | -6% | 257k | 58.13 |
|
| Vaxcyte (PCVX) | 0.2 | $15M | -6% | 257k | 58.13 |
|
| Silence Therapeutics Ads (SLN) | 0.2 | $15M | -37% | 1.3M | 10.98 |
|
| Silence Therapeutics Ads (SLN) | 0.2 | $15M | -37% | 1.3M | 10.98 |
|
| Apyx Medical Corporation (APYX) | 0.2 | $15M | -4% | 3.3M | 4.49 |
|
| Apyx Medical Corporation (APYX) | 0.2 | $15M | -4% | 3.3M | 4.49 |
|
| Jefferson Capital (JCAP) | 0.2 | $15M | 750k | 19.47 |
|
|
| Jefferson Capital (JCAP) | 0.2 | $15M | 750k | 19.47 |
|
|
| Planet Fitness Master Issuer Cl A (PLNT) | 0.2 | $15M | NEW | 279k | 52.17 |
|
| Planet Fitness Master Issuer Cl A (PLNT) | 0.2 | $15M | NEW | 279k | 52.17 |
|
| Rh (RH) | 0.2 | $14M | -19% | 87k | 164.73 |
|
| Rh (RH) | 0.2 | $14M | -19% | 87k | 164.73 |
|
| Verastem Com New (VSTM) | 0.2 | $14M | 3.6M | 3.82 |
|
|
| Verastem Com New (VSTM) | 0.2 | $14M | 3.6M | 3.82 |
|
|
| Lawson Products (DSGR) | 0.2 | $14M | 495k | 27.35 |
|
|
| Lawson Products (DSGR) | 0.2 | $14M | 495k | 27.35 |
|
|
| Rayonier Advanced Matls (RYAM) | 0.2 | $13M | +6% | 1.7M | 7.86 |
|
| Rayonier Advanced Matls (RYAM) | 0.2 | $13M | +6% | 1.7M | 7.86 |
|
| Helix Acquisition Corp Iii Usd Cl A Ord Shs (HLXC) | 0.2 | $13M | 1.3M | 10.64 |
|
|
| Helix Acquisition Corp Iii Usd Cl A Ord Shs (HLXC) | 0.2 | $13M | 1.3M | 10.64 |
|
|
| Adc Therapeutics Sa SHS (ADCT) | 0.2 | $13M | +120% | 12M | 1.07 |
|
| Adc Therapeutics Sa SHS (ADCT) | 0.2 | $13M | +120% | 12M | 1.07 |
|
| Ocuphire Pharma (IRD) | 0.2 | $13M | +82% | 3.1M | 4.11 |
|
| Ocuphire Pharma (IRD) | 0.2 | $13M | +82% | 3.1M | 4.11 |
|
| Janux Therapeutics (JANX) | 0.2 | $12M | 810k | 15.36 |
|
|
| Janux Therapeutics (JANX) | 0.2 | $12M | 810k | 15.36 |
|
|
| Amanat Acquisition Corp Cl A Ord (AMAN) | 0.2 | $12M | NEW | 1.2M | 10.16 |
|
| Amanat Acquisition Corp Cl A Ord (AMAN) | 0.2 | $12M | NEW | 1.2M | 10.16 |
|
| Inspire Med Sys (INSP) | 0.2 | $12M | NEW | 270k | 44.61 |
|
| Inspire Med Sys (INSP) | 0.2 | $12M | NEW | 270k | 44.61 |
|
| 1 800 Flowers Cl A (FLWS) | 0.2 | $12M | 3.4M | 3.48 |
|
|
| 1 800 Flowers Cl A (FLWS) | 0.2 | $12M | 3.4M | 3.48 |
|
|
| X4 Pharmaceuticals Com New (XFOR) | 0.2 | $11M | 2.4M | 4.67 |
|
|
| X4 Pharmaceuticals Com New (XFOR) | 0.2 | $11M | 2.4M | 4.67 |
|
|
| Integer Hldgs (ITGR) | 0.2 | $10M | -35% | 111k | 93.45 |
|
| Integer Hldgs (ITGR) | 0.2 | $10M | -35% | 111k | 93.45 |
|
| Inventiva Sa Ads (IVA) | 0.2 | $10M | NEW | 2.7M | 3.78 |
|
| Inventiva Sa Ads (IVA) | 0.2 | $10M | NEW | 2.7M | 3.78 |
|
| Industrial Logistics Pptys T Com Shs Ben Int (ILPT) | 0.2 | $9.9M | -33% | 1.1M | 8.87 |
|
| Industrial Logistics Pptys T Com Shs Ben Int (ILPT) | 0.2 | $9.9M | -33% | 1.1M | 8.87 |
|
| Duolingo Cl A Com (DUOL) | 0.2 | $9.6M | -16% | 84k | 115.02 |
|
| Duolingo Cl A Com (DUOL) | 0.2 | $9.6M | -16% | 84k | 115.02 |
|
| Reservoir Media (RSVR) | 0.2 | $9.3M | 941k | 9.89 |
|
|
| Reservoir Media (RSVR) | 0.2 | $9.3M | 941k | 9.89 |
|
|
| Service Properties Trust Service Pptys Tr | 0.1 | $9.0M | -24% | 5.3M | 1.69 |
|
| Fractyl Health (GUTS) | 0.1 | $9.0M | -15% | 11M | 0.79 |
|
| Fractyl Health (GUTS) | 0.1 | $9.0M | -15% | 11M | 0.79 |
|
| Dhi (DHX) | 0.1 | $8.8M | 2.4M | 3.71 |
|
|
| Dhi (DHX) | 0.1 | $8.8M | 2.4M | 3.71 |
|
|
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $8.7M | -9% | 487k | 17.96 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $8.7M | -9% | 487k | 17.96 |
|
| Korro Bio (KRRO) | 0.1 | $8.7M | 660k | 13.18 |
|
|
| Korro Bio (KRRO) | 0.1 | $8.7M | 660k | 13.18 |
|
|
| Alector (ALEC) | 0.1 | $8.7M | +53% | 4.3M | 2.01 |
|
| Alector (ALEC) | 0.1 | $8.7M | +53% | 4.3M | 2.01 |
|
| Noodles & Co Cl A New (NDLS) | 0.1 | $8.3M | 554k | 14.95 |
|
|
| Noodles & Co Cl A New (NDLS) | 0.1 | $8.3M | 554k | 14.95 |
|
|
| Codexis (CDXS) | 0.1 | $8.2M | -12% | 3.6M | 2.26 |
|
| Codexis (CDXS) | 0.1 | $8.2M | -12% | 3.6M | 2.26 |
|
| Perspective Therapeutics Com New (CATX) | 0.1 | $7.9M | NEW | 2.3M | 3.41 |
|
| Perspective Therapeutics Com New (CATX) | 0.1 | $7.9M | NEW | 2.3M | 3.41 |
|
| Irenic Acquisition Corp Unit 04/10/2031 (IACQU) | 0.1 | $7.6M | NEW | 750k | 10.16 |
|
| Irenic Acquisition Corp Unit 04/10/2031 (IACQU) | 0.1 | $7.6M | NEW | 750k | 10.16 |
|
| Damora Therapeutics Com New | 0.1 | $7.2M | 278k | 26.01 |
|
|
| Damora Therapeutics Com New | 0.1 | $7.2M | 278k | 26.01 |
|
|
| Viemed Healthcare (VMD) | 0.1 | $7.2M | -28% | 632k | 11.40 |
|
| Viemed Healthcare (VMD) | 0.1 | $7.2M | -28% | 632k | 11.40 |
|
| Unicycive Therapeutics Com New (UNCY) | 0.1 | $6.6M | +49% | 1.4M | 4.69 |
|
| Unicycive Therapeutics Com New (UNCY) | 0.1 | $6.6M | +49% | 1.4M | 4.69 |
|
| Traeger Com New (COOK) | 0.1 | $6.5M | -19% | 83k | 78.83 |
|
| Traeger Com New (COOK) | 0.1 | $6.5M | -19% | 83k | 78.83 |
|
| Forrester Research (FORR) | 0.1 | $6.4M | +9% | 763k | 8.41 |
|
| Forrester Research (FORR) | 0.1 | $6.4M | +9% | 763k | 8.41 |
|
| Lexeo Therapeutics (LXEO) | 0.1 | $6.1M | +8% | 1.3M | 4.66 |
|
| Lexeo Therapeutics (LXEO) | 0.1 | $6.1M | +8% | 1.3M | 4.66 |
|
| Envoy Medical Cl A (COCH) | 0.1 | $6.0M | 7.7M | 0.78 |
|
|
| Envoy Medical Cl A (COCH) | 0.1 | $6.0M | 7.7M | 0.78 |
|
|
| Eloxx Pharmaceuticals Com New (ELOX) | 0.1 | $5.6M | NEW | 400k | 13.88 |
|
| Eloxx Pharmaceuticals Com New (ELOX) | 0.1 | $5.6M | NEW | 400k | 13.88 |
|
| Inhibikase Therapeutics Com New (IKT) | 0.1 | $5.5M | 2.7M | 2.03 |
|
|
| Inhibikase Therapeutics Com New (IKT) | 0.1 | $5.5M | 2.7M | 2.03 |
|
|
| First Tracks Biotherapeutics Ord Shs (TRAX) | 0.1 | $5.0M | NEW | 250k | 20.12 |
|
| First Tracks Biotherapeutics Ord Shs (TRAX) | 0.1 | $5.0M | NEW | 250k | 20.12 |
|
| Mara Holdings Note3/0 (Principal) | 0.1 | $5.0M | 5.0M | 1.00 |
|
|
| Mara Holdings Note3/0 (Principal) | 0.1 | $5.0M | 5.0M | 1.00 |
|
|
| Hain Celestial (HAIN) | 0.1 | $4.8M | 8.5M | 0.56 |
|
|
| Hain Celestial (HAIN) | 0.1 | $4.8M | 8.5M | 0.56 |
|
|
| Alta Equipment Group Common Stock (ALTG) | 0.1 | $4.7M | -22% | 725k | 6.47 |
|
| Alta Equipment Group Common Stock (ALTG) | 0.1 | $4.7M | -22% | 725k | 6.47 |
|
| Orthopediatrics Corp. (KIDS) | 0.1 | $4.6M | +21% | 242k | 19.13 |
|
| Orthopediatrics Corp. (KIDS) | 0.1 | $4.6M | +21% | 242k | 19.13 |
|
| Altimmune Com New (ALT) | 0.1 | $4.6M | NEW | 1.5M | 3.04 |
|
| Altimmune Com New (ALT) | 0.1 | $4.6M | NEW | 1.5M | 3.04 |
|
| Trisalus Life Sciences (TLSI) | 0.1 | $4.6M | -51% | 1.0M | 4.55 |
|
| Trisalus Life Sciences (TLSI) | 0.1 | $4.6M | -51% | 1.0M | 4.55 |
|
| Tela Bio (TELA) | 0.1 | $4.4M | 5.9M | 0.75 |
|
|
| Tela Bio (TELA) | 0.1 | $4.4M | 5.9M | 0.75 |
|
|
| One Group Hospitality In (STKS) | 0.1 | $4.3M | 2.1M | 2.01 |
|
|
| One Group Hospitality In (STKS) | 0.1 | $4.3M | 2.1M | 2.01 |
|
|
| Dariohealth Corp (DRIO) | 0.1 | $4.0M | 611k | 6.60 |
|
|
| Dariohealth Corp (DRIO) | 0.1 | $4.0M | 611k | 6.60 |
|
|
| Immunic Com New (IMUX) | 0.1 | $3.9M | NEW | 251k | 15.37 |
|
| Immunic Com New (IMUX) | 0.1 | $3.9M | NEW | 251k | 15.37 |
|
| Zai Lab Adr (ZLAB) | 0.1 | $3.8M | NEW | 200k | 19.00 |
|
| Zai Lab Adr (ZLAB) | 0.1 | $3.8M | NEW | 200k | 19.00 |
|
| Talphera Com New (TLPH) | 0.1 | $3.6M | 3.5M | 1.03 |
|
|
| Talphera Com New (TLPH) | 0.1 | $3.6M | 3.5M | 1.03 |
|
|
| Venu Hldg Corp (VENU) | 0.1 | $3.5M | -24% | 1.5M | 2.23 |
|
| Venu Hldg Corp (VENU) | 0.1 | $3.5M | -24% | 1.5M | 2.23 |
|
| Payoneer Global (PAYO) | 0.1 | $3.4M | 484k | 7.12 |
|
|
| Payoneer Global (PAYO) | 0.1 | $3.4M | 484k | 7.12 |
|
|
| Elutia Cl A Com (ELUT) | 0.1 | $3.1M | 3.2M | 0.98 |
|
|
| Elutia Cl A Com (ELUT) | 0.1 | $3.1M | 3.2M | 0.98 |
|
|
| Kailera Therapeutics Common Stock (KLRA) | 0.1 | $3.1M | NEW | 140k | 22.03 |
|
| Kailera Therapeutics Common Stock (KLRA) | 0.1 | $3.1M | NEW | 140k | 22.03 |
|
| Rallybio Corp (RLYB) | 0.1 | $3.0M | -37% | 188k | 16.00 |
|
| Rallybio Corp (RLYB) | 0.1 | $3.0M | -37% | 188k | 16.00 |
|
| Artiva Biotherapeutics (ARTV) | 0.0 | $2.9M | NEW | 300k | 9.70 |
|
| Artiva Biotherapeutics (ARTV) | 0.0 | $2.9M | NEW | 300k | 9.70 |
|
| Destination Xl (DXLG) | 0.0 | $2.8M | 4.1M | 0.67 |
|
|
| Destination Xl (DXLG) | 0.0 | $2.8M | 4.1M | 0.67 |
|
|
| Editas Medicine (EDIT) | 0.0 | $2.8M | NEW | 853k | 3.24 |
|
| Editas Medicine (EDIT) | 0.0 | $2.8M | NEW | 853k | 3.24 |
|
| eHealth (EHTH) | 0.0 | $2.6M | 1.8M | 1.49 |
|
|
| eHealth (EHTH) | 0.0 | $2.6M | 1.8M | 1.49 |
|
|
| Jatt Ii Acquisition Corp Ord Shs (JATT) | 0.0 | $2.6M | NEW | 225k | 11.36 |
|
| Jatt Ii Acquisition Corp Ord Shs (JATT) | 0.0 | $2.6M | NEW | 225k | 11.36 |
|
| Arvinas Ord (ARVN) | 0.0 | $2.5M | 300k | 8.31 |
|
|
| Arvinas Ord (ARVN) | 0.0 | $2.5M | 300k | 8.31 |
|
|
| Reading Intl Cl A (RDI) | 0.0 | $2.5M | 1.9M | 1.28 |
|
|
| Reading Intl Cl A (RDI) | 0.0 | $2.5M | 1.9M | 1.28 |
|
|
| Inspiremd (NSPR) | 0.0 | $2.4M | 3.4M | 0.70 |
|
|
| Inspiremd (NSPR) | 0.0 | $2.4M | 3.4M | 0.70 |
|
|
| Aytu Biopharma (AYTU) | 0.0 | $2.3M | 1.1M | 2.15 |
|
|
| Aytu Biopharma (AYTU) | 0.0 | $2.3M | 1.1M | 2.15 |
|
|
| Akebia Therapeutics (AKBA) | 0.0 | $2.3M | 2.0M | 1.14 |
|
|
| Akebia Therapeutics (AKBA) | 0.0 | $2.3M | 2.0M | 1.14 |
|
|
| Scully Royalty Com Shs (SRL) | 0.0 | $2.3M | 368k | 6.12 |
|
|
| Scully Royalty Com Shs (SRL) | 0.0 | $2.3M | 368k | 6.12 |
|
|
| Entrada Therapeutics (TRDA) | 0.0 | $2.2M | +88% | 301k | 7.36 |
|
| Entrada Therapeutics (TRDA) | 0.0 | $2.2M | +88% | 301k | 7.36 |
|
| Gaia Cl A (GAIA) | 0.0 | $1.9M | 915k | 2.10 |
|
|
| Gaia Cl A (GAIA) | 0.0 | $1.9M | 915k | 2.10 |
|
|
| America's Car-Mart (CRMT) | 0.0 | $1.8M | 645k | 2.79 |
|
|
| America's Car-Mart (CRMT) | 0.0 | $1.8M | 645k | 2.79 |
|
|
| Alx Oncology Hldgs (ALXO) | 0.0 | $1.6M | NEW | 750k | 2.07 |
|
| Alx Oncology Hldgs (ALXO) | 0.0 | $1.6M | NEW | 750k | 2.07 |
|
| Precision Optics Corp Inc Ma Com New (POCI) | 0.0 | $1.4M | 280k | 5.10 |
|
|
| Precision Optics Corp Inc Ma Com New (POCI) | 0.0 | $1.4M | 280k | 5.10 |
|
|
| BRC Com Cl A | 0.0 | $1.4M | -52% | 1.3M | 1.11 |
|
| BRC Com Cl A | 0.0 | $1.4M | -52% | 1.3M | 1.11 |
|
| Vyne Therapeutics (VYNE) | 0.0 | $1.3M | 2.0M | 0.65 |
|
|
| Vyne Therapeutics (VYNE) | 0.0 | $1.3M | 2.0M | 0.65 |
|
|
| Curis | 0.0 | $1.0M | 2.0M | 0.52 |
|
|
| Altisource Portfolio Solutio *w Exp 04/30/203 (ASPSW) | 0.0 | $991k | 2.5M | 0.40 |
|
|
| Altisource Portfolio Solutio *w Exp 04/30/203 (ASPSW) | 0.0 | $991k | 2.5M | 0.40 |
|
|
| Senti Biosciences Holdings Com New (SNTI) | 0.0 | $977k | NEW | 888k | 1.10 |
|
| Acme United Corporation (ACU) | 0.0 | $975k | 20k | 47.72 |
|
|
| Acme United Corporation (ACU) | 0.0 | $975k | 20k | 47.72 |
|
|
| Perfect Corp Cl A Ord Shs (PERF) | 0.0 | $969k | 584k | 1.66 |
|
|
| Perfect Corp Cl A Ord Shs (PERF) | 0.0 | $969k | 584k | 1.66 |
|
|
| Altisource Portfolio Solutio *w Exp 04/02/202 (ASPSZ) | 0.0 | $694k | 2.5M | 0.28 |
|
|
| Altisource Portfolio Solutio *w Exp 04/02/202 (ASPSZ) | 0.0 | $694k | 2.5M | 0.28 |
|
|
| Cellectar Biosciences Com New (CLRB) | 0.0 | $612k | NEW | 220k | 2.78 |
|
| Cellectar Biosciences Com New (CLRB) | 0.0 | $612k | NEW | 220k | 2.78 |
|
| Spar (SGRP) | 0.0 | $546k | 661k | 0.83 |
|
|
| Spar (SGRP) | 0.0 | $546k | 661k | 0.83 |
|
|
| Azitra Com New (AZTR) | 0.0 | $371k | NEW | 2.2M | 0.17 |
|
| Azitra Com New (AZTR) | 0.0 | $371k | NEW | 2.2M | 0.17 |
|
| Biomx Com New (PHGE) | 0.0 | $215k | +453% | 635k | 0.34 |
|
| Biomx Com New (PHGE) | 0.0 | $215k | +453% | 635k | 0.34 |
|
| Aprea Therapeutics Com New (APRE) | 0.0 | $165k | 206k | 0.80 |
|
|
| Aprea Therapeutics Com New (APRE) | 0.0 | $165k | 206k | 0.80 |
|
|
| Guardforce Ai *w Exp 10/01/202 | 0.0 | $5.4k | 154k | 0.04 |
|
|
| Guardforce Ai *w Exp 10/01/202 | 0.0 | $5.4k | 154k | 0.04 |
|
Past Filings by Nantahala Capital Management
SEC 13F filings are viewable for Nantahala Capital Management going back to 2011
- Nantahala Capital Management 2026 Q2 amended filed Aug. 19, 2026
- Nantahala Capital Management 2026 Q2 filed Aug. 14, 2026
- Nantahala Capital Management 2026 Q1 filed May 15, 2026
- Nantahala Capital Management 2025 Q4 filed Feb. 13, 2026
- Nantahala Capital Management 2025 Q3 filed Nov. 14, 2025
- Nantahala Capital Management 2025 Q2 filed Aug. 14, 2025
- Nantahala Capital Management 2025 Q1 filed May 15, 2025
- Nantahala Capital Management 2024 Q4 filed Feb. 14, 2025
- Nantahala Capital Management 2024 Q3 filed Nov. 14, 2024
- Nantahala Capital Management 2024 Q2 amended filed Aug. 20, 2024
- Nantahala Capital Management 2024 Q2 filed Aug. 14, 2024
- Nantahala Capital Management 2024 Q1 filed May 15, 2024
- Nantahala Capital Management 2023 Q4 amended filed Feb. 15, 2024
- Nantahala Capital Management 2023 Q4 filed Feb. 14, 2024
- Nantahala Capital Management 2023 Q3 filed Nov. 14, 2023
- Nantahala Capital Management 2023 Q2 filed Aug. 14, 2023